title: The correlation of clinical efficacy, serum trough levels and antidrug antibodies in ustekinumab-treated patients with psoriasis in a clinical-practice setting.
authors: Department of Dermatology, Academic Medical Center, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands. s.p.menting@amc.uva.nl.
authors: S P
authors: SP
authors: Menting
authors: Department of Dermatology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.
authors: J M P A
authors: JM
authors: van den Reek
authors: Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
authors: E M
authors: EM
authors: Baerveldt
authors: Department of Dermatology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands.
authors: E M G J
authors: EM
authors: de Jong
authors: Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
authors: E P
authors: EP
authors: Prens
authors: Department of Dermatology, Academic Medical Center, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands.
authors: L L A
authors: LL
authors: Lecluse
authors: Department of Immunopathology, Sanquin Research, Amsterdam, the Netherlands.
authors: G J
authors: GJ
authors: Wolbink
authors: Department of Immunopathology, Sanquin Research, Amsterdam, the Netherlands.|Biologicals Laboratory, Sanquin Diagnostic Services, Amsterdam, the Netherlands.
authors: D
authors: D
authors: Van der Kleij
authors: Department of Dermatology, Academic Medical Center, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands.
authors: Ph I
authors: PI
authors: Spuls
authors: Department of Immunopathology, Sanquin Research, Amsterdam, the Netherlands.
authors: T
authors: T
authors: Rispens
mesh_terms: D000906:Antibodies / Q000378:metabolism; D000941:Antigens / Q000378:metabolism; D001665:Binding Sites; D003879:Dermatologic Agents / Q000276:immunology / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011565:Psoriasis / Q000097:blood / Q000188:drug therapy*; D000069549:Ustekinumab / Q000276:immunology / Q000493:pharmacokinetics* / Q000627:therapeutic use
chemical_list: D000906:Antibodies; D000941:Antigens; D003879:Dermatologic Agents; D000069549:Ustekinumab